Cargando…

Clinical and histopathological predictors of rapid kidney function decline in patients with biopsy-proven diabetic kidney disease

Detalles Bibliográficos
Autores principales:	Zhao, Yiyang, Chang, Dongyuan, Wu, Liang, Yu, Xiaojuan, Wang, Suxia, Zhao, Minghui, Chen, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278754/ https://www.ncbi.nlm.nih.gov/pubmed/37083123 http://dx.doi.org/10.1097/CM9.0000000000002673

Ejemplares similares

Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease
por: Lee, Yu Ho, et al.
Publicado: (2021)

Clinical and Pathological Features of Chinese Patients with Type 2 Diabetes, Biopsy-Proven Diabetic Kidney Disease, and Rapid eGFR Decline
por: Qin, Chunmei, et al.
Publicado: (2022)

Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2019)

Association between COL4A3 variant rs55703767 and susceptibility to diabetic kidney disease in patients with type 2 diabetes mellitus: results from the INDEED cohort study
por: Li, Zihan, et al.
Publicado: (2022)

Analysis of biopsy-proven nephrotic syndrome in Tibetan patients
por: Huang, Rongshuang, et al.
Publicado: (2022)

Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors
por: Chen, Yue, et al.
Publicado: (2016)

Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis
por: Corthier, Alice, et al.
Publicado: (2022)

Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria
por: Nasr, Samih H., et al.
Publicado: (2021)

Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
por: Groothof, Dion, et al.
Publicado: (2023)

Comment on: Renal histopathology spectrum in children with kidney diseases in Saudi Arabia
por: Alhasan, Khalid
Publicado: (2020)

Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis
por: Chen, Xuejing, et al.
Publicado: (2022)

Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy‐proven diabetic kidney disease: A multicenter cohort study
por: Shimizu, Miho, et al.
Publicado: (2023)

C3c deposition predicts worse renal outcomes in patients with biopsy‐proven diabetic kidney disease in type 2 diabetes mellitus
por: Li, Meng‐Rui, et al.
Publicado: (2022)

Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage
por: Lu, Xiao, et al.
Publicado: (2023)

Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease
por: Park, Ji In, et al.
Publicado: (2012)

Real world outcomes of biopsy‐proven oncocytic neoplasm of the kidney managed by surveillance
por: Rodger, Flora E., et al.
Publicado: (2022)

Mesoamerican Nephropathy and Kidney Disease Progression: A Case Series of Individuals With Kidney Biopsies From Nicaragua and El Salvador
por: Wijkström, Julia, et al.
Publicado: (2021)

Kidney Biopsy Techniques to Differentiate Calcium Oxalate and Dihydroxyadenine Tubular Crystals
por: Ibrahim, Dalia, et al.
Publicado: (2022)

Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery
por: Zoutendijk, J., et al.
Publicado: (2019)

Kidney biopsy in west of Iran: Complications and histopathological findings
por: Rahbar, M.
Publicado: (2009)

Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies
por: Liapis, H., et al.
Publicado: (2016)

Kidney histopathological findings in fatal pandemic 2009 influenza A (H1N1)
por: Nin, Nicolás, et al.
Publicado: (2011)

Biopsy-proven renal disease in Ile-Ife, Nigeria: A histopathologic review
por: Onwubuya, I. M., et al.
Publicado: (2016)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
por: Xiao, Xiang, et al.
Publicado: (2022)

Guilty until proven innocent?
por: McAnally, Heath B
Publicado: (2022)

Clinicopathological Characteristics and Risk Factors for Rapid eGFR Decline in Chinese Patients with Biopsy-Proven Obesity-Related Glomerulopathy
por: Yang, Jia, et al.
Publicado: (2023)

Gerontolizing Nephrology: Spectrum of Histopathological Findings of Kidney Biopsy in the Elderly
por: Beniwal, Pankaj, et al.
Publicado: (2020)

Histopathological and Clinical Findings of Biopsy-Proven Focal and Segmental Glomerulosclerosis: A Retrospective Study
por: Alhozali, Hanadi M, et al.
Publicado: (2022)

A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy
por: Joo, Woo Chul, et al.
Publicado: (2012)

Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review
por: Sawada, Anri, et al.
Publicado: (2018)

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients
por: Strassl, Robert, et al.
Publicado: (2019)

Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study
por: Haridasan, Satish, et al.
Publicado: (2021)

Kidney Function Decline in Young Adulthood and Subsequent 24-Hour Ambulatory Blood Pressure in Midlife: The CARDIA Study
por: Ghazi, Lama, et al.
Publicado: (2021)

Clinical and histopathological analyses of kidney biopsies in a single center for 7 years
por: Lee, Seunghye, et al.
Publicado: (2022)

Inpatient Native Kidney Biopsies and Glomerular Disease: Utilization and Diagnostic Trends in the United States, 2006-2015
por: Tran, Vinh V., et al.
Publicado: (2021)

In Favor of Controlling Proven, but Not Probable, Causes of Cancer
por: Erren, Thomas C., et al.
Publicado: (2011)

Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience
por: Teh, Cheng Lay, et al.
Publicado: (2018)

Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy
por: Marc-Alexander, Ohlow, et al.
Publicado: (2018)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
por: Gupta, Shruti, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_clqui13p63n7fvd84uquf9ngu1